Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5181388 | 0.88 | FTO (0.47) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL4519856 | 0.87 | FTO (0.63) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL2772536 | 0.85 | FTO (0.43) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL991335 | 0.83 | FTO (0.73) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL32675203 | 0.83 | FTO (0.73) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL7600556 | 0.82 | FTO (0.56) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL8664828 | 0.82 | FTO (0.43) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL17688356 | 0.82 | FTO (0.72) | FTOMAPTMEN1KMT2AHPGD | |
| Ammonia Solution, Strong SCHEMBL29101292 | 0.82 | FTO (0.72) | FTOMAPTMEN1KMT2AHPGD | |
| Naphthalene SCHEMBL7980446 | 0.80 | FTO (0.69) | FTOMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025426-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2025-01-23 | — | — | US | claimed |
| EP-0411038-A1 | PROCESS FOR FORMING AND USING MICRODROPLETS. | MASSACHUSETTS INST TECHNOLOGY (US) | 1991-02-06 | — | — | EP | claimed |
| WO-1989010566-A1 | PROCESS FOR FORMING AND USING MICRODROPLETS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-11-02 | — | — | WO | claimed |
| US-20250025426-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2025-01-23 | — | — | US | disclosed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | disclosed |
| WO-2023091674-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2023-05-25 | — | — | WO | disclosed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | disclosed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | disclosed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | disclosed |
| CN-108697789-A | Methods of treating influenza A | 免疫医疗有限责任公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108495653-A | The method for being used to prepare glycosylation pattern antibody with definition | 免疫医疗有限责任公司 | 2018-09-04 | — | — | CN | disclosed |
| WO-2016087674-A1 | PHARMACEUTICAL FORMULATION HAVING REVERSE THERMAL GELATION PROPERTIES FOR LOCAL DELIVERY OF NANOPARTICLES | EXCHANGE IMAGING TECHNOLOGIES GMBH (DE) | 2016-06-09 | — | — | WO | disclosed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | disclosed |
| EP-2126122-A1 | METHOD AND TEST KIT FOR DETERMINING THE AMOUNTS OF TARGET SEQUENCES AND NUCLEOTIDE VARIATIONS THEREIN | Valtion Teknillinen Tutkimuskeskus (FI) | 2009-12-02 | — | — | EP | disclosed |
| WO-2009072726-A1 | METHOD FOR LARGE SCALE PREPARATION OF THE ACTIVE DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE WITHOUT FUSION PROTEIN | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2009-06-11 | — | — | WO | disclosed |
| US-20090011944-A1 | METHOD AND TEST KIT FOR DETECTING NUCLEOTIDE VARIATIONS | VALTION TEKNILLINEN TUTKIMUSKEKUS (FI) | 2009-01-08 | — | — | US | disclosed |
| WO-2008102057-A9 | METHOD AND TEST KIT FOR DETERMINING THE AMOUNTS OF TARGET SEQUENCES AND NUCLEOTIDE VARIATIONS THEREIN | VALTION TEKNILLINEN (FI) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008102057-A1 | METHOD AND TEST KIT FOR DETERMINING THE AMOUNTS OF TARGET SEQUENCES AND NUCLEOTIDE VARIATIONS THEREIN | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 2008-08-28 | — | — | WO | disclosed |
| WO-2005019446-A2 | NOVEL FORM OF PROTEIN TYROSINE PHOSPHATASES AND METHODS FOR IDENTIFYING MOLECULES BINDING THERETO | TONKS NICHOLAS K (US) | 2005-03-03 | — | — | WO | disclosed |
| EP-0182179-B1 | INTEGRAL MULTILAYER ANALYTICAL ELEMENT FOR USE IN THE MEASUREMENT OF ALKALINE PHOSPHATASE ACITIVITY | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-18 | — | — | EP | disclosed |